| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/23/2012 | US20120045777 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 02/23/2012 | US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 02/23/2012 | US20120045755 Her-2 binding antagonists |
| 02/23/2012 | US20120045512 Methods and substrates for differentiation of neural stem cells |
| 02/23/2012 | US20120045504 oral drug devices and drug formulations |
| 02/23/2012 | US20120045502 Antagonists of muc1 |
| 02/23/2012 | US20120045501 Connexin enhances chemotherapy-included apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 02/23/2012 | US20120045487 Multiphasic microfibers for spatially guided cell growth |
| 02/23/2012 | US20120045484 Calcium phosphate/sulfate-based bone implant composition |
| 02/23/2012 | US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof |
| 02/23/2012 | US20120045464 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 02/23/2012 | US20120045462 Inflammation Inhibiting Compounds |
| 02/23/2012 | US20120045460 Methods and compositions for treatment of graft rejection and promotion of graft survival |
| 02/23/2012 | US20120045458 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22 |
| 02/23/2012 | US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 02/23/2012 | US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 02/23/2012 | US20120045449 Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease |
| 02/23/2012 | US20120045432 B lymphocyte stimulator assays |
| 02/23/2012 | US20120045431 Method of stabilizing and sterilizing peptides or proteins |
| 02/23/2012 | US20120045430 Dendrimer-like modular delivery vector |
| 02/23/2012 | US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface |
| 02/23/2012 | US20120045426 Compositions for reducing the deleterious effects of stress and aging |
| 02/23/2012 | US20120045425 Delta 4, 5 glycuronidase compositions and methods related thereto |
| 02/23/2012 | US20120045419 Methods and uses of hypoxic compartment cells |
| 02/23/2012 | US20120045415 Treatment of hepatitis c virus with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha 2a/2b and ribavirin |
| 02/23/2012 | US20120045414 Adjuvant combinations comprising a microbial tlr agonist, a cd40 or 4-1bb agonist, and optionally an antigen and the use thereof for inducing a synergistic enhancement in cellular immunity |
| 02/23/2012 | US20120045413 Human papilloma virus peptide-specific T-cell response for treatment of warts |
| 02/23/2012 | US20120045412 Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
| 02/23/2012 | US20120045411 Short beta-defensin-derived peptides |
| 02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display |
| 02/23/2012 | US20120045393 Lhrh-ii peptide analogs |
| 02/23/2012 | US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor |
| 02/23/2012 | US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages |
| 02/23/2012 | US20120045364 Multi-part substitution infusion fluids and matching anticoagulants |
| 02/23/2012 | US20120042613 Long-Term Storage of Non-Glycosylated Recombinant Human G-CSF |
| 02/23/2012 | CA2809022A1 Phospholipid depot |
| 02/23/2012 | CA2808668A1 Tam receptors and tam receptor ligands in detection and modulation of neuropathological disease |
| 02/23/2012 | CA2808596A1 Modified relaxin polypeptides and their uses |
| 02/23/2012 | CA2808165A1 Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events |
| 02/23/2012 | CA2808019A1 Particulate substances comprising ceramic particles for delivery of biomolecules |
| 02/23/2012 | CA2807343A1 Designer osteogenic proteins |
| 02/22/2012 | EP2420516A1 Rapid generation of T cell-independent antibody responses to T cell-dependent antigens |
| 02/22/2012 | EP2420255A2 Polypeptide inhibitors of urokinase type plasminogen activator |
| 02/22/2012 | EP2420249A1 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2012 | EP2420248A1 Mutated HIV NEF for modulating immunity |
| 02/22/2012 | EP2420245A1 Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth |
| 02/22/2012 | EP2420244A1 Lipid metabolism-improving agent |
| 02/22/2012 | EP2420229A1 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 02/22/2012 | EP2419442A1 3d matrices of human elastin-like polypeptides and method of preparation thereof |
| 02/22/2012 | EP2419440A1 Peptide ligands for clusterin and uses thereof |
| 02/22/2012 | EP2419439A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate |
| 02/22/2012 | EP2419438A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function |
| 02/22/2012 | EP2419126A1 Combination immunotherapy compositions against cancer and methods |
| 02/22/2012 | EP2419123A1 Novel post-translational fibrinogen variants |
| 02/22/2012 | EP2419122A2 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein) |
| 02/22/2012 | EP2419121A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof |
| 02/22/2012 | EP2419120A2 Human protein scaffold with controlled serum pharmacokinetics |
| 02/22/2012 | EP2419119A1 Muscle function enhancing peptide |
| 02/22/2012 | EP2419118A1 Treating blurred vision and other conditions of the eye with cyclosporin composition |
| 02/22/2012 | EP2419117A2 Methionine sulfoxide peptide, compositions and methods of use |
| 02/22/2012 | EP2419116A1 Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
| 02/22/2012 | EP2419111A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof |
| 02/22/2012 | EP2418941A1 Enzyme delivery systems and methods of preparations and use |
| 02/22/2012 | EP2390261A9 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof |
| 02/22/2012 | EP2371840A9 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes |
| 02/22/2012 | EP2361988A9 Molecular marker for cancer stem cell |
| 02/22/2012 | EP1968623B1 Bacteriocin inducer peptides |
| 02/22/2012 | EP1803732B1 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 02/22/2012 | EP1740608B1 Modified human growth hormone polypeptides and their uses |
| 02/22/2012 | EP1648496B1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 02/22/2012 | EP1648494B1 Anti-angiogenetic agent and its use in cancer treatment |
| 02/22/2012 | EP1633387B1 Combinations of tumor-associated antigens for the treatment of various types of cancers |
| 02/22/2012 | EP1615655B1 Use of compositions for mucosal and oral administration comprising hcg fragments |
| 02/22/2012 | EP1575531B9 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 02/22/2012 | EP1531850B1 Use of IL-21 and monoclonal antibody for treating solid cancers |
| 02/22/2012 | EP1255555B1 NON-MAMMALIAN GnRH ANALOG AND USES THEREOF IN REGULATING FERTILITY AND PREGNANCY |
| 02/22/2012 | EP0979080B9 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/22/2012 | CN1943780B 胰激肽原酶在制备放射治疗肿瘤的药物中的应用 Pancreatic kallikrein in the manufacture of a medicament for radiation therapy of cancer |
| 02/22/2012 | CN1854151B 多巴胺转运蛋白拟肽抑制剂及其应用 Peptidomimetic inhibitor of dopamine transporter and its application |
| 02/22/2012 | CN102361979A Peptide capable of binding to immunoglobulin |
| 02/22/2012 | CN102361647A Fgf21 derivatives with albumin binder a-b-c-d-e- and their use |
| 02/22/2012 | CN102361646A Compounds and methods for modulating immune response |
| 02/22/2012 | CN102358753A Trypsin inhibitor active fragment derivative, and preparation method and application thereof |
| 02/22/2012 | CN102358752A GLP-1 and exendin related invention |
| 02/22/2012 | CN102357263A Composite inducer for promoting autologous peripheral preadipocyte proliferation and enlargement for cosmesis and body beautification and preparation method thereof |
| 02/22/2012 | CN102357245A Purpose of composite of non-crystallin betagamma-crystallin and trefoil factor |
| 02/22/2012 | CN102357244A Healthcare product for irregular menstruation |
| 02/22/2012 | CN102357243A Recombinant cattle basic fibroblastic growth factor eye drops |
| 02/22/2012 | CN102357242A Recombination cattle alkaline fibroblast growth factor gel |
| 02/22/2012 | CN102357084A Enalapril maleate tablet composition and its preparation and use |
| 02/22/2012 | CN102357062A Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 02/22/2012 | CN101985470B 胰高血糖素样多肽-1类似物及其制备方法与应用 Glucagon-like peptide 1 analog and preparation method and application |
| 02/22/2012 | CN101983722B 一种用于防治关节软组织损伤及并发炎症的组合物 A method for prevention and treatment of joint and soft tissue injury and inflammation concurrent composition |
| 02/22/2012 | CN101875922B 一种重组苛求芽孢杆菌胞内尿酸酶及其聚乙二醇修饰与应用 A recombinant Bacillus cells within demanding its PEGylated uricase and Applications |
| 02/22/2012 | CN101816705B 三针注射及熏蒸治疗股骨头坏死的药物及制备方法 Three injections and drug fumigation treatment of femoral head necrosis and preparation methods |
| 02/22/2012 | CN101573129B 用于皮肤病学用途的包含昆诺阿藜谷物提取物的组合物 The composition for dermatological use comprising quinoa cereal extract |
| 02/22/2012 | CN101381412B 聚合物/重组人促红素偶联物 Polymer / recombinant human erythropoietin conjugates |
| 02/22/2012 | CN101247794B 阿肽地尔的制剂 A peptide formulations Seoul |
| 02/22/2012 | CN101153054B 用于血管生成治疗的小肽及其应用 Angiogenic therapy for small peptide and its application |
| 02/22/2012 | CN101027084B 用于调节免疫的突变型hiv nef Mutant hiv nef for regulating immunity |